Argus® II Retinal Stimulation System Feasibility Protocol

Clinical Trial

NCT00407602 Completed

Argus® II Retinal Stimulation System Feasibility Protocol.

Phase 3

Interventional

Disease

Disease type

Paediatric clinical trials

Retinitis Pigmentosa

Orphan drug recognition

Patient type

Adult

Children

Inclusion / Exclusion

Opening date

01/01/2008

Closing date

01/01/2019

Inclusion criteria :

Exclusion criteria :

Funding

industry

Members involved

Main investigators

Pr José-Alain Sahel

France

Genetic Diagnostics (TWG6), Low Vision Daily Life and Patients Groups (TWG5), Neuro-Ophthalmology Rare Diseases (WG2), Pediatric Ophthalmology Rare Diseases (WG3), Registries & Epidemiology (TWG7), Research (TWG8), Retinal Rare Eye Diseases (WG1)

Others investigators

Pr Isabelle Audo

Representative

France

Genetic Diagnostics (TWG6), Low Vision Daily Life and Patients Groups (TWG5), National Integration (TWG9), Neuro-Ophthalmology Rare Diseases (WG2), Pediatric Ophthalmology Rare Diseases (WG3), Registries & Epidemiology (TWG7), Research (TWG8), Retinal Rare Eye Diseases (WG1)